← Leaderboards
John Travis Hinson
Brigham And Women'S Hospital
$8,448,361
Attributed
$9,519,702
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,519,702 · 7
By mechanism
R01$4,906,812 · 3
U01$3,198,616 · 2
K08$803,260 · 1
R61$611,014 · 1
Top collaborators
- Stuart G Campbell4 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Rong Tian$29,765,984
- Hyon K Choi$12,976,398
- Marcie A Glicksman$6,112,045
- Jian Zhu$8,103,274
- Eileen Patricia Scully$4,644,342
Others in their field
Top investigators on “Cardiac Myocytes”
- Joseph C Wu · Stanford University$53,447,011
- Donald M Bers · Cincinnati Childrens Hosp Med Ctr$50,074,770
- Jeffery D Molkentin · Cincinnati Childrens Hosp Med Ctr$40,971,477
- Piero Anversa · New York Medical College$40,584,258
- Junichi Sadoshima · Rutgers Biomedical And Health Sciences$34,907,735
- Steven R Houser · Johns Hopkins University$33,565,081
Research focus
Cardiac MyocytesCellsMolecularGeneticCardiacGenesResponseInsightInduced Pluripotent Stem CellStructureIn VivoDilated CardiomyopathyHeart FailureHypertrophic CardiomyopathyMutationInheritedLinkGenome EditingEngineering3-DimensionalBiomimeticsHeartResourcesTranscriptome Sequencing
Grant awards (21)
Pathogenicity and pathophysiology assessments of sarcomere gene variants identified in the clinic$615,006
R01 · FY2025 · HL · contact PI
AAV therapies for TNNT2-associated cardiac disorders$611,014
R61 · FY2025 · HL · contact PI
Establishing and reversing the functional consequences of Titin truncation mutations$529,054
R01 · FY2025 · HL · contact PI
Establishing and reversing the functional consequences of Titin truncation mutations$518,473
R01 · FY2024 · HL · contact PI
Establishing and reversing the functional consequences of Titin truncation mutations$529,054
R01 · FY2023 · HL · contact PI
Human cardiac microtissues with innate immune sensing to study adverse consequences of genome editing$737,026
U01 · FY2022 · HL · contact PI
Establishing and reversing the functional consequences of Titin truncation mutations$566,102
R01 · FY2022 · HL · contact PI
SCGE Disease Models Studies Supplement: Cardioediting Ttntvs in a humanized mouse model$232,382
U01 · FY2022 · HL · contact PI
Human cardiac microtissues with innate immune sensing to study adverse consequences of genome editing$737,975
U01 · FY2021 · HL · contact PI
Comprehensive Analysis of Allelic, Cellular and Molecular Heterogeneity in Human 3-Dimensional Cardiac Microtissues with MYH7 Mutations$539,937
R01 · FY2021 · HL · contact PI
Human cardiac microtissues with innate immune sensing to study adverse consequences of genome editing$738,903
U01 · FY2020 · HL · contact PI
Comprehensive Analysis of Allelic, Cellular and Molecular Heterogeneity in Human 3-Dimensional Cardiac Microtissues with MYH7 Mutations$539,937
R01 · FY2020 · HL · contact PI
Human cardiac microtissues with innate immune sensing to study adverse consequences of genome editing$752,330
U01 · FY2019 · EB · contact PI
Comprehensive Analysis of Allelic, Cellular and Molecular Heterogeneity in Human 3-Dimensional Cardiac Microtissues with MYH7 Mutations$531,981
R01 · FY2019 · HL · contact PI
Metabolic and developmental regulation by AMPK in PRKAG2-associated cardiomyopathy$177,120
K08 · FY2019 · HL · contact PI
Comprehensive Analysis of Allelic, Cellular and Molecular Heterogeneity in Human 3-Dimensional Cardiac Microtissues with MYH7 Mutations$537,268
R01 · FY2018 · HL · contact PI
Metabolic and developmental regulation by AMPK in PRKAG2-associated cardiomyopathy$177,120
K08 · FY2018 · HL · contact PI
Metabolic and developmental regulation by AMPK in PRKAG2-associated cardiomyopathy$177,120
K08 · FY2017 · HL · contact PI
Metabolic and developmental regulation by AMPK in PRKAG2-associated cardiomyopathy$115,202
K08 · FY2016 · HL · contact PI
Metabolic and developmental regulation by AMPK in PRKAG2-associated cardiomyopathy$20,748
K08 · FY2016 · HL · contact PI
Metabolic and developmental regulation by AMPK in PRKAG2-associated cardiomyopathy$135,950
K08 · FY2015 · HL · contact PI